SCHEMBL18922285

SCHEMBL18922285

C[C@@](CCO)(C[C@@H](Cc1ccc(-c2ccccc2F)cc1)NC(=O)c1cn(O)nn1)C(=O)O

nearest known ligand 0.60

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ MME P08473 18/20 0.60
▸ ACE P12821 4/20 0.46
▸ CTSA P10619 1/20 0.44
▸ MMEL1 Q495T6 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15466952 0.93 MME (0.69) MMEACECTSA
SCHEMBL19788072 0.93 MME (0.69) MMEACECTSA
SCHEMBL12481962 0.93 MME (0.69) MMEACECTSA
SCHEMBL12481917 0.85 MME (0.80) MMEACEMMEL1
SCHEMBL11969648 0.85 MME (0.80) MMEACEMMEL1
SCHEMBL11969654 0.80 MME (0.53) MMEACECTSA
SCHEMBL24350626 0.80 MME (0.51) MMEACEMMEL1
SCHEMBL21351167 0.80 MME (0.51) MMEACEMMEL1
SCHEMBL19688101 0.79 MME (0.58) MMEACE
SCHEMBL24350873 0.79 MME (0.56) MMEACEMMEL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9670186-B2 Neprilysin inhibitors THERAVANCE BIOPHARMA R&D IP, LLC (US) 2017-06-06 — — US disclosed
Send feedback